COVID-flu combination vaccine shows 'positive' results in late-stage trials, Moderna says

Moderna, which is developing a combination COVID-flu vaccine, announced on Monday that in phase 3 clinical trials, mRNA-1083 achieved a better immune response than other vaccines.

Related Keywords

United States ,Virginia ,Americans ,Marc Siegel ,Amrie Grammer ,Francesca Ceddia ,Melissa Rudy ,National Institutes Of Health ,Pfizer ,Centers For Disease ,Langone Medical Center ,Fox News ,National Institutes ,Medical Center ,Disease Control ,News Digital ,